APETx2 (TFA)
Partner: MedChemexpress LLC
| Applications: | COVID-19-immunoregulation |
| MW: | 4675.02 |
| Formula: | C198H281F3N54O62S6 |
| SMILES: | OC(C(F)(F)F)=O.O=C(N[C@@H]([C@H](O)C)C(N[C@@H](C)C(N[C@@H](CSSC[C@@H]1NC2=O)C(N[C@@H](CO)C(N[C@@H](CSSC[C@@H](C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC3=CC=C(C=C3)O)C(N[C@@H](CC4=CC=CC=C4)C(N[C@@H](CC(C)C)C(NCC(N[C@H]2[C@H](O)C)=O)=O)=O)=O)=O)=O)NC5=O)C(NCC(N[C@@H](CC(N)=O)C(N[C@@H](CO)C(N[C@@H](CCCCN)C(NCC(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC6=CC=C(C=C6)O)C(N[C@@H](CC7=CNC8=CC=CC=C78)C(N[C@@H](CC9=CC=CC=C9)C(N[C@@H](CC%10=CC=C(C=C%10)O)C(N[C@@H](CCCNC(N)=N)C(N%11[C@@H](CCC%11)C(N[C@@H](CO)C(N[C@@H](CSSC[C@@H](C(N[C@@H]([C@H](O)C)C(N%12[C@@H](CCC%12)C(N[C@@H](C)C(N[C@@H](CC(O)=O)C(O)=O)=O)=O)=O)=O)NC1=O)C(N%13[C@@H](CCC%13)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCNC(N)=N)C(NCC(N[C@@H](CC%14=CC=C(C=C%14)O)C(N[C@@H]([C@H](O)C)C(NCC(N[C@H]5CO)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CN.OC(C(F)(F)F)=O |
| Purity: | 98.38 |
| Description: | APETx2 TFA, a sea anemone peptide from Anthopleura elegantissima, is a selective and reversible ASIC3 inhibitor, with an IC50 of 63 nM. APETx2 directly inhibits the ASIC3 channel by acting at its external side. APETx2 could reverses acid?induced and inflammatory pain[1][2]. |
| Shipping Conditions: | Ship on cold packs |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
